Educational information, not medical advice — ask your doctor or midwife.
Tejpatra (Cinnamomum tamala) is the leaf of a tree native to the Himalayan foothills and northeastern India, related to cinnamon and cassia. It has been a fundamental ingredient in both Ayurvedic medicine and Indian cuisine for thousands of years, valued equally for its warm, clove-like aroma and its therapeutic properties. Unlike Mediterranean bay leaf (Laurus nobilis), tejpatra has a distinctly spicier, cinnamony profile and a richer medicinal tradition.
Tejpatra works through several overlapping pathways: its cinnamaldehyde and eugenol content supports healthy insulin sensitivity and helps the body process blood sugar more efficiently. Its volatile oils have notable antimicrobial and anti-inflammatory properties, and compounds like quercetin and tannins provide antioxidant protection. Together, these compounds help calm digestive discomfort, reduce oxidative stress, and support metabolic health.
Whole dried leaves are most commonly simmered in cooking or brewed as herbal tea. Powdered leaf can be encapsulated or added to food. The essential oil is used topically and in aromatherapy. Aqueous (water-based) extracts are used in traditional preparations and are the form most studied in clinical and preclinical research.
Tejpatra is referenced in classical Ayurvedic texts including the Charaka Samhita and Sushruta Samhita, where it is classified under the category of 'deepaniya' (digestive stimulant) and 'shoolaprashamana' (pain-relieving) herbs. It has been part of South Asian cooking and medicine continuously for over 3,000 years, used to treat everything from digestive complaints to respiratory congestion and fever.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
Reviewed by the HealisticMD editorial team How we grade evidence →
The published evidence for Tejpatra is weak or absent. That usually means no controlled trial has tested it, not that a trial found it ineffective — the two are different, and we grade only what has been published.
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.